{"id":191,"count":1,"description":"","link":"https:\/\/pharmaceuticalcarrier.com\/index.php\/tag\/example-of-a-level-2-change-under-the-fdas-supac-guidelines\/","name":"example of a Level 2 change under the FDA's SUPAC guidelines","slug":"example-of-a-level-2-change-under-the-fdas-supac-guidelines","taxonomy":"post_tag","meta":[],"_links":{"self":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/tags\/191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/tags"}],"about":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/taxonomies\/post_tag"}],"wp:post_type":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/posts?tags=191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}